General Information of the Compound
Compound ID
CP0286134
Compound Name
(E)-3-[6-(2,6-Dichloro-phenylsulfanylmethyl)-3-phenethyloxy-pyridin-2-yl]-acrylic acid
    Show/Hide
Synonyms
LTB4 antagonist, SB
SB-209247
Ticolubant
    Show/Hide
Structure
Formula
C23H19Cl2NO3S
Molecular Weight
460.382
Canonical SMILES
OC(=O)\C=C\c1nc(CSc2c(Cl)cccc2Cl)ccc1OCCc1ccccc1
    Show/Hide
InChI
InChI=1S/C23H19Cl2NO3S/c24-18-7-4-8-19(25)23(18)30-15-17-9-11-21(20(26-17)10-12-22(27)28)29-14-13-16-5-2-1-3-6-16/h1-12H,13-15H2,(H,27,28)/b12-10+
    Show/Hide
InChIKey
ZJLFOOWTDISDIO-ZRDIBKRKSA-N
CAS
154413-61-3
Physicochemical Property
logP
6.4
Rotatable Bonds
9
Heavy Atom Count
30
Polar Areas
59.42
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 6441619
SID: 14906989
ChEMBL ID
CHEMBL90214
Clinical Information about the Compound
Drug 1 ( SB-209247 )
Drug Name SB-209247
Company SmithKline Beecham plc
Indication
Psoriasis vulgaris
Terminated
Target(s)
Leukotriene B4 receptor 1 (LTB4R)
Antagonist